Merck announced the expansion of its high-potent active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) production capabilities and capacity at…
Royal DSM has opened new facility the Rosalind Franklin Biotechnology Centre at the Delt campus, theNetherlands.
The building was developed with an investment of €100m ($106m). The new facility will be engaged in research and development (R&D) in food and nutrition, as well as feed, fuel, pharmaceuticals, and bio-based materials.
The facility is named after scientist Rosalind Franklin, who worked to understand the structures of DNA and created the basis for modern biotechnology.
Supplier of food enzymes, ingredients, and hydrocolloids DSM Food Specialties is also headquartered at the same site.
Design and features of Rosalind Franklin Biotechnology Center
The Rosalind Franklin Biotechnology Center has a total floor space of 13,800m², including offices and laboratories. The building features 3,000m² of glass panes and a 22mx9m glass roof.
The building’s ground floor is used for enzymes research using state-of-the-art nuclear magnetic resonance technology. The first floor features screening facilities for bacterial strains, while other floors are used for bioprocess development.
The laboratory side of the building is intended for storage and equipment areas, while the office side contains an atrium with a fully-glazed panoramic lift.
The centre will also include a Food Innovation Centre and Wetering office on the site, which are expected to be connected in the future.
The facility is located on the Delft site, where DSM Food Specialties has global headquarters along with a pilot fermentation plant. It replaces the existing Beijerinck lab constructed in 1984 with state-of-the-art lab equipment and systems.
The biotechnology centre accommodates more than 400 R&D experts from 27 nationalities. It will facilitate a broad range of biotechnology specialisations under one roof and features an auditorium with two large meeting rooms.
One of the research areas of focus at the centre is production of fermentative steviol glycosides from stevia plant in order to address the growing demand for low-sugar food and beverages. The facility has also developed a new technology that turns an unpalatable agricultural by-product of rapeseed or canola into a valuable plant protein.
The Rosalind Franklin Biotechnology Centre was constructed in compliance with building research establishment environmental assessment method (BREEAM) standards.
Heijmans was awarded a contract for the construction of the biotechnology centre. The construction was completed in September 2016.
Deerns was awarded a contract to provide design and procurement of the mechanical, electrical, and plumbing (MEP) systems for the facility.
Cepezed Architects provided design for the biotechnology centre, while Fokkema & Partners Architecten developed the new and innovative concepts for the office space and the interior design.
MTSA Technopower delivered lab infrastructure and auxiliary equipment including 40 fermentation work stations for the new biotechnology centre in November 2016.
Royal HaskoningDHV served as the project manager.
Marketing commentary on DSM
DSM delivers food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials in the global market.
The company has a workforce of approximately 25,000.
POINT Biopharma, a clinical-stage biopharmaceutical company, is planning to construct its first US manufacturing plant in Indianapolis, Indiana. The investment…
Neopharma opened a pharmaceutical plant in Abu Dhabi, United Arab Emirates, in July 2003. The plant then entered a three-month…